Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis

Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system in which immune mechanisms appear to be an important component of the pathophysiology. Although the clinical manifestations are variable, a subset of patients develops a progressive clinical course associated with marked neurologic impairment and significant morbidity. BMT has been proposed as a treatment for such patients based on preclinical data as well as clinical observations in other autoimmune diseases. We report clinical and MRI findings in an MS patient, later diagnosed with CML, and treated with an allogeneic BMT.

Author information

Affiliations

Authors

Corresponding author

Correspondence to LD McAllister.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

McAllister, L., Beatty, P. & Rose, J. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 19, 395–397 (1997). https://doi.org/10.1038/sj.bmt.1700666

Download citation

Keywords

  • multiple sclerosis
  • allogeneic BMT
  • autoimmune disease

Further reading

Search

Quick links